White Atractylodes is a dried East Asian herbal stem used for digestion and vitality. Human evidence remains rated Low at best and indirect: multi-herb formulas show bowel, blood sugar, and blood pressure signals, with aging effects confined to rodent and cell studies. Short-term oral use appears generally well tolerated, but long-term safety data are absent and laboratory studies flag theoretical bleeding, birth-defect, and drug-interaction risks. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum ALT and AST | ALT: 19–25 IU/L in females, 29–33 IU/L in males; AST: 10–40 IU/L | Detects herb- or interaction-related liver injury |
| Fasting plasma glucose | 70–99 mg/dL | Tracks glucose lowering and screens for hypoglycemia |
| HbA1c | 4.0–5.6% | Evaluates three-month glycemic response |
| Serum potassium | 3.5–5.0 mmol/L | Monitors electrolytes given diuretic actions and preclinical aldosterone inhibition |
| Bilirubin | Not specified in the ER | Paired with ALT and AST for liver-injury stopping thresholds |
| Seated blood pressure | Not specified in the ER | Safety check commonly paired with morning serum potassium draw |
Cadence: At baseline, then ALT, AST, fasting plasma glucose, and serum potassium at 4–8 weeks after initiation or dose escalation, HbA1c at 12 weeks, and the complete panel every 6 months during extended cyclical use, with prompt unscheduled testing for persistent nausea, dark urine, dizziness, or unusual bruising.